A pragmatic, multicentre, double-blind, placebocontrolled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial.

Details

Language :

English

ISSN :

13665278

Volume :

27

Issue :

23/24

Database :

Complementary Index

Journal :

Health Technology Assessment

Publication Type :

Academic Journal

Accession number :

173393346

Full Text :

https://doi.org/10.3310/VPDT7105